UBS Group »

Bridgebio Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $738k 750k 0.98
2024-12-31 $2.3M 2.7M 0.85

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Bridgebio Pharma

Linden Advisors
Wolverine Asset Management
Camden Asset Management
Sona Asset Management
Ing Investment Management
Steelhead Partners
Davidson Kempner Capital Management
MacKay Shields
D. E. Shaw & Co
Jump Financial
Wells Fargo & Company
Advent Capital Management
Laurion Capital Management
State Street Corporation
Lazard Asset Management

View all funds holding Bridgebio Pharma